Previous 10 | Next 10 |
2023-03-17 10:02:41 ET Gainers: Enzo Biochem ( ENZ ) +77% . PaxMedica ( PXMD ) +22% . Nuwellis (NUWE ) +18% . Lucy Scientific Discovery ( LSDI ) +12% . Assure Holdings ( IONM ) +8% . Losers: Lifecore Biomedical (...
2023-03-17 08:33:13 ET Diebold Nixdorf DBD -28% on liquidity concerns . Sarepta Therapeutics SRPT -18% on FDA advisory meeting for its muscular dystrophy treatment . ThermoGenesis ( THMO ) -19% . First Republic Bank FRC -15% after suspending d...
2023-03-09 08:10:06 ET Shares of Emergent BioSolutions ( NYSE: EBS ) are up 5% in premarket trading after a number of institutional investors and hedge funds increased their holdings. Eagle Asset Management Inc. owns 160,153 shares with a value of $3.361M following a p...
Emergent BioSolutions (NYSE: EBS) probably wishes it had stayed in bed on Tuesday. The company's stock declined by nearly 12% that day, following its release of quarterly results that fell well short of expectations on the bottom line. For its fourth quarter of 2022, Emergent booked rev...
Gainers: Cardio Diagnostics ( CDIO ) +159% . Bioventus ( BVS ) +68% . CNS Pharmaceuticals ( CNSP ) +24% . Bullfrog AI ( BFRG ) +20% . SI-BONE ( SIBN ) +19% . Losers: ContraFect ( CFRX ) -24% . AdaptHealth ( AHCO ) ...
The following slide deck was published by Emergent BioSolutions Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Emergent BioSolutions Inc. 2022 Q4 - Results - Earnings Call Presentation
Emergent BioSolutions Inc. (EBS) Q4 2022 Earnings Conference Call February 27, 2023, 5:00 PM ET Company Participants Bob Burrows - Vice President, Investor Relations Bob Kramer - President and CEO Rich Lindahl - Chief Financial Officer Conference Call Participant...
Image source: The Motley Fool. Emergent BioSolutions (NYSE: EBS) Q4 2022 Earnings Call Feb 27, 2023 , 5:00 p.m. ET Operator Continue reading For further details see: Emergent BioSolutions (EBS) Q4 2022 Earnings Call Transcript
Emergent Biosolutions press release ( NYSE: EBS ): Q4 Non-GAAP EPS of -$0.31 misses by $0.25 . Revenue of $330.7M (-54.3% Y/Y) beats by $32.47M . Sees FY 2023 revenue of $1.10B to $1.20B. The consensus FY 2023 revenue estimate is $1.17B. Sees Q1 2023 revenue of...
Reports Q4 2022 total revenues of $331M resulting in FY 2022 total revenues of $1,121M, in line with prior guidance Reports Q4 2022 net loss of $88M and FY 2022 net loss of $224M Reports Q4 2022 adjusted EBITDA of $34M and FY 2022 adjusted EBITDA of $26M, in line with prior guidance R...
News, Short Squeeze, Breakout and More Instantly...
Emergent Biosolutions Inc. Company Name:
EBS Stock Symbol:
NYSE Market:
Emergent Biosolutions Inc. Website:
2024-05-03 06:53:00 ET 3 Ways That Penny Stocks Can Help Diversify Your Portfolio benefits due to their distinct characteristics and pricing. When integrated thoughtfully, penny stocks can inject a dynamic layer into an investment strategy, balancing traditional investments with the...
Emergent BioSolutions, Inc. (NYSE:EBS) shares surged higher Thursday after the company announced operational changes to stabilize its financial pos...
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging over 200 points on Thursday. The Dow traded up 0.87% to 38,2...